Kevo-Prophen

Manufacturer
Faeve, LLC
Effective date
2026-04-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:54:23

Label at a glance#

ProductKevo-Prophen
Active ingredientJUNIPER TAR
Label structure9 sections

Dosage and administration

Adults and children 2 years of age and older; Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: do not use, consult a physician.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Juniperus Oxycedrus (Juniper Tar Oil) 1%

Purpose

OTC - PURPOSE SECTION

pain reliever

Use

INDICATIONS & USAGE SECTION

For the temporary relief of pain

Warnings

WARNINGS SECTION

  • For External Use Only
  • Use only as directed
  • Read and follow directions on label
  • Avoid contact with eyes and muscous membranes.
  • If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a physician.
  • If pregnant or breast feeding, ask a physician before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact Poison Control Center right away.

DO NOT USE

OTC - DO NOT USE SECTION

  • on puncture wounds
  • on cut, irritated, or open skin.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults and children 2 years of age and older; Apply to affected area not more than 3 to 4 times daily.
  • Children under 2 years of age: do not use, consult a physician.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Abies Balsamea Needle Oil, beta-Caryophyllene, Bisabolol, Calophyllum lnophyllum Seed Oil*, Carthamus
Tinctorius Oleosomes, Cedrus Deodara Wood Oil, Cetearyl Alcohol, Cetearyl Olivate, Cetyl Palmitate,
Copaifera Officinalis, Glyceryl Stearate SE, Lecithinl, Litsea Cubeba, Methylsulfonylmethane, Nigella Sativa
Seed Oil*, Ocimum Basilicum Oil, Origanum Vulgare, Persea Gratissima, Piper Nigrum Seed Oil, Potassium
Sorbate, Pullulan, Salix Nigra Bark Extract, Sclerotium Gum, Sodium Benzoate, Sorbitan Oleate, Sorbitan
Olivate, Stearic Acid, Theobroma Cacao Seed Butter, Vanilla Planifolia Oil, Water (Aqua), Xanthan Gum.

Questions or Comments

OTC - QUESTIONS SECTION

www.faeveusa.com

(352) 593-3352

Made in USA

Package - Box

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

boxbox

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130619567788582GTIN-13: 0619567788582
EAN-13: 0619567788582
GTIN-12: 619567788582
UPC-A: 619567788582
GTIN storage (14 digits): 00619567788582
kevo-profen box.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87607-001-01Kevo-Prophen1 in 1 BOXCREAM11
87607-001-01Kevo-Prophen98 mL in 1 BOTTLE, PUMPCREAM981

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 33 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87607-00187607-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 32 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Kevo-ProphenJUNIPER TARFaeve, LLC4fe773a8-77cd-831e-e063-6294a90ae2ca2026-04-20WarningsExact identifier
ndc (package): 87607-001-01
ndc (product): 87607-001
ndc11 (package): 87607000101
spl id: 4fe773a8-77ce-831e-e063-6294a90ae2ca
spl set id: 4fe773a8-77cd-831e-e063-6294a90ae2ca

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.